NCT07350148 Opioid Adherence and Support Through Innovative Texting Strategies
| NCT ID | NCT07350148 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of New Mexico |
| Condition | Opioid Use Disorder (OUD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-10-13 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-10-13 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to examine the effects of reminder and mindfulness text messages on medication adherence and managing craving, pain, and withdrawal symptoms in people taking medications for opioid use disorder through assessment questions collected twice daily during the course of treatment. The main questions it aims to answer are: 1. Do daily medication reminder text messages increase medication adherence for people taking medications for opioid use disorder? 2. To what extent do people engage with the daily mindfulness messages? 3. What impact does daily mindfulness text message quantity have on craving, pain, forgetfulness, and withdrawal symptoms? Participants will: 1. Receive daily medication reminder text messages for at least 24 weeks (i.e., 6 months) 2. Receive up to 6 mindfulness messages per day for 4 weeks (i.e., 1 month) 3. Answer daily questions twice a day during the 4 weeks of mindfulness messages 4. Answer questions about the study when enrolling, at the end of the 4 weeks of mindfulness messages, and at 4 and 16 weeks after the end of the mindfulness messages
Eligibility Criteria
Inclusion Criteria: * 18 years of age or older * Have a cellphone that can receive text messages * Have internet access to complete study surveys * Willing to comply with all study procedures and be available for the duration of the study * Within 6 months of starting or resuming to take daily methadone or buprenorphine (or suboxone/subutex) * Able to understand study requirements and provide informed consent Exclusion Criteria: * None
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07350148 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Opioid Use Disorder (OUD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07350148 currently recruiting?
Yes, NCT07350148 is actively recruiting participants. Contact the research team at fschwebel@unm.edu for enrollment information.
Where is the NCT07350148 trial being conducted?
This trial is being conducted at Albuquerque, United States.
Who is sponsoring the NCT07350148 clinical trial?
NCT07350148 is sponsored by University of New Mexico. The trial plans to enroll 60 participants.